The analysis points to a worrying trend, namely that Germany is experiencing a decline in its position as a leading location for pharmaceutical research and development, with a widening gap from the global forefront.
← all excerpts
Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany-A Mixed-Methods Study on Enrollment Potential Based on Claims Data.
1
—
—